Through bioinformatics analyses, we identified a key immune- and metabolism-associated molecule PLA2G2D that was significantly related to better prognosis of CSCC patients and more immune cell infiltration. This evidence concerns the gene PLA2G2D and skin squamous cell carcinoma.